Navigation Links
Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women

SAN DIEGO, Calif., April 14 /PRNewswire-USNewswire/ -- Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit have been studying racial disparities related to cancer patients. Today, at the American Association for Cancer Research (AACR) Annual Meeting, Karmanos researchers Vitaly Balan, Ph.D., Pratima Nangia-Makker, Ph.D., and Avraham Raz, Ph.D., presented their abstract, Galectin-3 nsSNP rs4644 Foretells Human Breast Cancer Risk Associated with Racial Disparity, exploring factors that suggest why Caucasian women have a significantly higher risk of developing breast cancer than Asian women. This research was done in collaboration with investigators from Karmanos Cancer Institute, in Michigan; Mayo Clinic, in Minnesota; and Zhengzhou University, in China.

(Logo: )

Breast cancer is the most common cancer among women, according to the American Cancer Society, and it is the second leading cause of cancer deaths among women in the United States, estimated at more than 40,000 this year alone. It's estimated that in 2007 there were 178,480 new cases of invasive breast cancer and another 62,000 of in situ breast cancer, and Caucasian women are far more prone to develop breast cancer than Asian women, for reasons unknown.

Although the mutations in BRCA1 and BRCA2 were identified as genetic risk factors for breast cancer more than a decade ago, they only account for five percent of the breast cancer cases. The discovery of additional genes that might also prove significant for breast cancer has been limited especially as related to racial differences in the breast cancer incidences.

Researchers studied galectin-3 which is widely expressed in various tumor cells and its expression is correlated with tumorigenesis, tumor progression and metastasis.

Analysis of galectin-3 variants in the DNA of blood, normal and cancerous tissues of Asian and Caucasian women revealed that galectin-3 is expressed as either histidine at position 64 (H64) or proline (P64) and is associated in part with increased risk for the development of breast cancer.

The breakdown of the data revealed that 64% of the disease-free control Caucasian women were either homozygous (12%) or heterozygous (52%) for H64 and the remaining 36% were homozygous for P64. In contrast, 30% of the disease-free control Asian women carried at least one H64 allele, of which 5% were homozygous and 25% were heterozygous and the remaining 70% were homozygous for P64.

The analysis distribution of the polymorphism of galectin-3 in Caucasian and Asian breast cancer patients showed that about 70% and 90% of the tumor samples from Caucasians and Asians, respectively, harbor the H64 allele, of which approximately 35% of the Caucasians and 70% of the Asians were homozygous for the H64 allele.

"This study suggests that a gene(s) is responsible for the racial disparity between Caucasian and Asian women breast cancer incidence, so we need to look beyond lifestyle influences, such as diet, exercise and environment and consider other genetic markers like Galectin-3 H64 as a possible contributor to breast cancer," said Avraham Raz, Ph.D.

Dr. Raz added, "Further research is needed but the suggestion of Galectin-3-H64 as a contributor in breast cancer is significant."

Funding for the study was provided by the National Institutes of Health and the Barbara Ann Karmanos Cancer Institute's Strategic Research Grant.

The Barbara Ann Karmanos Cancer Institute

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 39 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. John C. Ruckdeschel, M.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to

American Association for Cancer Research

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field.

SOURCE Karmanos Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
2. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
3. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
4. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
5. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
6. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
7. U. of Md. Researchers to Develop Devices to Revolutionize Drug Research
8. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
9. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
10. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
11. Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
Post Your Comments:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  The American ... and Gynecologists (ACOG), and the March of Dimes ... Protecting Our Infants Act of 2015 ... number of newborns born exposed to drugs, such ... the bill,s introduction, all three organizations have worked ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 26, 2015 , ... ... Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public ... in Nairobi (UNON) for the opening of the 5th African Network for Drugs ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, ... Two Organizations, One Beat ” campaign. The partnership between the two groups began in ... in MAP International’s cause. , MAP International was founded in 1954 and is an ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... people across the country to celebrate their sobriety and show through pictures what ... “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law ... successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys ... Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock ...
Breaking Medicine News(10 mins):